Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-03-21
2010-06-22
Aeder, Sean E (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07741464
ABSTRACT:
The present invention discloses a method for treating cancer by using hCRMP1 and/or active fragments thereof, as well as the active fragments of hCRMP1 that are capable of inhibiting cell proliferation, invasive activity, and metastasis of cancer. The method can also be used prior to, or in combination with, the administration a chemotherapy agent. A vector capable of expressing an hCRMP1, a variant of hCRMP1, a fragment of hCRMP1 or a variant of a fragment of hCRMP1 is also disclosed.
REFERENCES:
patent: 6046173 (2000-04-01), Forstova et al.
patent: 7354709 (2008-04-01), Yang et al.
patent: 2002/0168637 (2002-11-01), Wang et al.
patent: 2003/0077624 (2003-04-01), Yang et al.
patent: 1 271 153 (2003-01-01), None
patent: 1 271 153 (2003-01-01), None
patent: WO 2004/113566 (2004-12-01), None
Vivest et al (JBC, Jun. 1997, 272(25): 16010-16017).
International Search Report from the European Patent Office, issued in International Application No. PCT/US2008/003724, dated Aug. 22, 2008 (8 pages), and Written Opinion of the International Searching Authority (10 pages).
Jin-Yuan Shih et al., “Collapsin Response Mediator Protein-1 and the Invasion and Metastasis of Cancer Cells”, Journal of the National Cancer Institute, Service, 93:(18)1392-1400 (2001).
Jin-Yuan Shih et al., “Collapsin Response Mediator Protein-1: A novel invasion-suppressor gene”, Clinical & Experimental Metastasis, 20:69-76 (2003).
Database UniProt:Q96I11—Human (1 page) (2001).
Database EMBL:CR601364 (2 pages) (2004).
Database EMBL:AL535253 (2 pages) (2001).
Database EMBL:CD579803 (2 pages) (2003).
Database EMBL:DA517748 (2 pages) (2005).
Albarran, et al., “A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells”, Protein Engineering, Design & Selection 18(3):147-152 (2005).
Byk et al., “Identification and molecular characterization of unc-33-like phosphoprotein (Ulip), a putative mammalian homology of the axonal guidance-associated unc-33 gene product”, J. Neurosci. 16:688-701 (1996).
Chu, et al., “Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line”, Am. J. Respir. Cell Mol. Biol., 17:353-360 (1997).
De Coupade, et al., “Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules”, Biochem. J. 390:407-418 (2005).
Harada, et al., “Antitumor Protein Therapy; Application of the Protein Transduction Domain to the Development of a Protein Drug for Cancer Treatment”, Breast Cancer, 13(1)16-26 (2006).
Inagaki et al., “Differential expression of dihydropyrimidinase-related protein genes in developing and adult enteric nervous system”,Histochem. Cell Biol.,113:37-41(2000).
Li et al., “Analysis of theCaenohabditis elegansAxonal Guidance and outgrowth Geneunc-33”, Genetics, 132(3): 675-689 (1992).
Lin, et al., “Enhanced cell-permanent Cre protein for site-specific recombination in cultured cells”, BMC Biotechnology, 4:25 (2004).
Lindsay, et al., “Peptide-mediated cell delivery: application in protein target validation”, Pharmacology, 2:587-594 (2002).
Mamot, et al., “Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells”, Cancer Research 63:3154-3161 (2003).
Matsuo et al., “Structure and promoter analysis of the humanunc-33-like phosphoprotein gene: E-box required for maximal expression in neuroblastoma and myoblasts”,J. Biol. Chem.,275: 16560-16568 (2000).
Shih et al., “Collapsin Response Mediator Protein-1 and the Invasion and Metastasis of Cancer Cells”,J. Natl. Cancer Inst.,93(18): 1392-1400 (2001).
Shih et al., “Collapsin Response Mediator Protein-1: A Novel Invasion-Suppressor Gene”,Clinical&Exper. Metastasis,20: 69-76 (2003).
Torres and Polymeropoulos, “Genomic organization and localization of human CRMP-1 gene”, DNA Res 5:393-395 (1998).
Vivés, et al., “A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus”, The Journal of Biological Chemistry, 272(25):16010-16017 (1997).
Lee Woan-Jen
Lee Yi-Jen
Terng Harn-Jing
Advpharma Inc.
Aeder Sean E
Hsiu-Ming Saunders Intellectual Property Connections, Inc.
LandOfFree
Compositions and methods of using CRMP-1 and its fragments... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of using CRMP-1 and its fragments..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of using CRMP-1 and its fragments... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4208179